GNH USA

Europe — EMA

Moxonidine Eg

GNH USA supplies Moxonidine Eg (Moxonidine), an imidazoline receptor agonist for hypertension. GMP‑certified and suitable for hospitals and pharmacies.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidine Eg, is an imidazoline receptor agonist presented as an oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Moxonidine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is used to manage conditions within the hypertension disease family.

Essential hypertension: reduces systolic and diastolic blood pressure. Primary hypertension: assists in achieving guideline‑recommended blood‑pressure targets. Elevated blood pressure: contributes to overall cardiovascular risk reduction.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions.

Common Side Effects: - Dry mouth - Fatigue - Dizziness - Headache - Nausea - Insomnia

Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reactions (rash, angioedema) - Elevated liver enzymes - Cardiac arrhythmia - Syncope

What precautions apply to Moxonidine?

When prescribing Moxonidine, consider the following precautions.

Monitor blood pressure: check regularly after initiation. Assess renal function: adjust dose if impairment is present. Avoid abrupt discontinuation: taper under medical supervision. Caution in elderly: increased sensitivity to hypotensive effects. Store at room temperature: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with several drug classes.

Major Interactions (Avoid): - Concomitant use with other antihypertensives: risk of excessive hypotension. - Potassium‑sparing diuretics: additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia. - Central acting agents (e.g., clonidine): may require dose adjustment. - Alcohol: can increase dizziness.

Frequently asked questions

What is Moxonidine Eg used for?+
Moxonidine Eg contains the active ingredient moxonidine, which is prescribed to lower high blood pressure in adults. It belongs to the class of imidazoline receptor agonists and is used primarily for the treatment of essential hypertension.
How does moxonidine work to lower blood pressure?+
Moxonidine selectively stimulates imidazoline I1 receptors in the brainstem, reducing sympathetic nervous system activity. This leads to decreased peripheral vascular resistance and lower cardiac output, ultimately lowering arterial blood pressure.
What is the usual dose of Moxonidine Eg?+
The dosage of Moxonidine Eg is determined by the prescribing healthcare professional based on the individual’s condition, response, and any co‑existing medical issues. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Moxonidine safe during pregnancy or breastfeeding?+
Safety data for moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Moxonidine Eg from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Moxonidine compare with other antihypertensive drugs?+
Moxonidine differs from many antihypertensives because it targets central imidazoline I1 receptors rather than angiotensin‑converting enzyme or calcium channels. This mechanism can provide effective blood‑pressure control with a distinct side‑effect profile, making it an alternative for patients who need a different therapeutic approach.
What are the storage and handling requirements for Moxonidine Eg?+
Moxonidine Eg should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.
How is Moxonidine Eg administered?+
Moxonidine Eg is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Moxonidine Eg?+
Serious risks include severe hypotension, bradycardia, allergic reactions such as rash or angioedema, and rare liver enzyme elevations. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, or signs of an allergic response.
Who should not use Moxonidine Eg?+
Moxonidine Eg is contraindicated in patients with known hypersensitivity to moxonidine or any component of the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled heart failure, or those taking multiple central antihypertensive agents.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Eurogenerics N.V./S.A.
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU